Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,415,375
-
Share change
-
-669,343
-
Total reported value
-
$50,480,000
-
Price per share
-
$2.60
-
Number of holders
-
26
-
Value change
-
-$147,781
-
Number of buys
-
14
-
Number of sells
-
7
Institutional Holders of PIERIS PHARMACEUTICALS INC - COM (PIRS) as of Q1 2017
As of 31 Mar 2017,
PIERIS PHARMACEUTICALS INC - COM (PIRS) was held by
26 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,415,375 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, Tekla Capital Management LLC, Lombard Odier Asset Management (USA) Corp, BVF INC/IL, Omega Fund Management, LLC, SPHERA FUNDS MANAGEMENT LTD., RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, EAM Investors, LLC, and BlackRock Inc..
This page lists
26
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.